The protective effects of estrogen on the cardiovascular system.

By M. Mendelsohn, R. Karas. New England Journal of Medicine, 2002

2,094 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Genetics

View Paper: https://www.semanticscholar.org/paper/b51252053354ad3185504ac1f2390253dd36899d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. E. Fish

In Epidemiology

1. E. Fish

In Genetics

1. Vera Regitz-Zagrosek
2. Tyler J. VanderWeele
3. Georgios Kararigas
4. Stijn Vansteelandt
5. E. Fish

Citations in the corpus

• Mechanistic Pathways of Sex Differences in Cardiovascular Disease. (2017, background): “raised high-density lipoprotein (HDL) cholesterol levels (261, 414), further implicating estrogen signaling in the regulation of lipid metabolism.”
• Odds ratios for mediation analysis for a dichotomous outcome. (2010, background): “estrogen therapy A on cardiovascular disease Y is mediated through serum lipid concentrations M and the extent to which it is through other pathways (3, 4).”
• 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. (2024, neutral): “37,38 Whereas the fall in endogenous oestrogen with menopause has been associated with hypertension, exogenous oestrogen-progesterone oral contraceptive drugs are a well-known cause of hypertension.”
• The X-files in immunity: sex-based differences predispose immune responses (2008, background): “Coxsackievirus B3 (CVB3) infection is associated with myocarditis 47 , and although men and women are equally susceptible to CVB3 infection, the cardioprotective effects of oestrogens have been linked to a lower incidence of heart disease in women 48 .”